Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

Andrew A. Lane, MD, PhD, Diederik van Bodegom, PhD, Bjoern Chapuy, MD, PhD, Gabriela Alexe, PhD, Timothy J Sullivan, PhD, Trevor Tivey, Tovah Day, PhD, John Crispino, PhD, Edward Fox, PhD, Kimberly Stegmaier, MD, David Weinstock, MD

Blood (2012) 120 (21): 115.

https://doi.org/10.1182/blood.V120.21.115.115

Published: 2012

Journal Articles

A Phase I Trial of Escalating Dose of the Rapamycin Analog Everolimus in Combination with the Kinase Inhibitor Midostaurin in Patients (pts) with Relapsed, Refractory or Poor Prognosis Acute Myeloid Leukemia (AML)

Richard M. Stone, MD, Caitlin Driscoll, Ilene Galinsky, ANP, Martha Wadleigh, MD, David P. Steensma, MD, David Avigan, MD, Philip C. Amrein, MD, Suiyang Liu, James D. Griffin, MD, Steven L. McAfee, MD, Eyal C. Attar, MD, Karen K. Ballen, MD, Edward Fox, PhD, Daniel J. DeAngelo, MD, PhD

Blood (2012) 120 (21): 3627.

https://doi.org/10.1182/blood.V120.21.3627.3627

Published: 2012

Journal Articles

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

Adam Cuker, Alasdair J. Coles, Herman Sullivan, Edward Fox, Mark Goldberg, Pedro Oyuela, Annie Purvis, Diana S. Beardsley, David H. Margolin

Blood (2011) 118 (24): 6299–6305.

https://doi.org/10.1182/blood-2011-08-371138

Published: 2011

Includes: Supplemental data

Journal Articles

Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation,

Oliver Weigert, MD, Nadja Kopp, Andrew A. Lane, MD, PhD, Akinori Yoda, PhD, Suzanne E. Dahlberg, PhD, Donna Neuberg, ScD, Anita Y Bahar, Bjoern Chapuy, MD, PhD, Frank Kuo, MD, PhD, Terry Haley, PhD, Timothy J Sullivan, Edward Fox, PhD, Scott J. Rodig, MD, PhD, Joseph H Antin, MD, David M Weinstock, MD

Blood (2011) 118 (21): 3671.

https://doi.org/10.1182/blood.V118.21.3671.3671

Published: 2011

Journal Articles

Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets

Sophia Adamia, Ph.D, Michal Bar-Natan, M.D, Benjamin Haibe-Kains, Ph.D, Hervé Avet-Loiseau, MD, PhD, Laurence Lode, Ph.D, Samuel Pevzner, Sigitas Verselis, PhD, Edward Fox, PhD, Ilene Galinsky, ANP, John Quackenbush, Ph.D, Richard M. Stone, MD, James D Griffin, MD

Blood (2011) 118 (21): 761.

https://doi.org/10.1182/blood.V118.21.761.761

Published: 2011

Journal Articles

Next Generation Sequencing Identifies Novel Oncogene Alterations In CRLF2- rearranged Precursor B-Cell Acute Lymphoblastic Leukemia

Akinori Yoda, Terry Haley, Oliver B. Weigert, Jeffery Kutok, MD, PhD, Adalis Maisonet, Maura Salois, Edward Fox, David M Weinstock

Blood (2010) 116 (21): 472.

https://doi.org/10.1182/blood.V116.21.472.472

Published: 2010

Journal Articles

Comparison of High Dose Chemotherapy with Autologous Stem Cell Rescue (ASCT) Versus Consolidation Chemotherapy for Patients < 60 with Cytogenetically Normal AML (CN-AML) and Flt3 ITD

Harshabad Singh, MBBS, Lillian Werner, Daniel J DeAngelo, MD, PhD, Philip C. Amrein, MD, Martha Wadleigh, M.D., Karen K Ballen, MD, Ilene Galinsky, ANP, Donna Neuberg, ScD, Edward Fox, Richard M Stone, M.D., Eyal C Attar, MD

Blood (2010) 116 (21): 3555.

https://doi.org/10.1182/blood.V116.21.3555.3555

Published: 2010

Journal Articles

Identification of Potential Therapeutic Targets Using Genome-Wide Analysis of Alternative Splicing (AS) In Patients with Acute Myeloid Leukemia (AML)

Sophia Adamia, Hervé Avet-Loiseau, Laurence Lodé, Michal Bar-Natan, Sigitas Verselis, PhD, Edward Fox, Ilene Galinsky, ANP, Philippe Moreau, Richard Stone, MD, James D. Griffin, MD

Blood (2010) 116 (21): 177.

https://doi.org/10.1182/blood.V116.21.177.177

Published: 2010

Journal Articles

The Anti-CD20 Monoclonal Antibody GA101 Displays More Robust Anti-Tumor Activity Versus Rituximab In Waldenstrom's Macroglobulinemia (WM)

Guang Yang, MD, Christina Hanzis, Sigitas Verselis, PhD, Lian Xu, Zachary Hunter, Leukothea Ioakimidis, Patricia Sheehy, NP, Christopher Patterson, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2010) 116 (21): 4904.

https://doi.org/10.1182/blood.V116.21.4904.4904

Published: 2010

Journal Articles

Clinical Outcomes of Acute Promyelocytic Leukemia (APL) Patients According to FLT3 Mutation Status

Harshabad Singh, MBBS, Lillian Werner, Daniel J DeAngelo, MD, PhD, Philip C. Amrein, MD, Martha Wadleigh, M.D., Karen K Ballen, MD, Edward Fox, Ilene Galinsky, ANP, Donna Neuberg, ScD, Richard M Stone, M.D., Eyal C Attar, MD

Blood (2010) 116 (21): 2689.

https://doi.org/10.1182/blood.V116.21.2689.2689

Published: 2010

Journal Articles

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells

Blood (2008) 112 (13): 5161–5170.

https://doi.org/10.1182/blood-2008-02-138065

Published: 2008

Includes: Supplemental data

Journal Articles

Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells

Ellen Weisberg, Lolita Banerji, Renee D. Wright, Rosemary Barrett, Arghya Ray, Daisy Moreno, Laurence Catley, Jingrui Jiang, Elizabeth Hall-Meyers, Maira Sauveur-Michel, Richard Stone, Ilene Galinsky, Edward Fox, Andrew L. Kung, James D. Griffin

Blood (2008) 111 (7): 3723–3734.

https://doi.org/10.1182/blood-2007-09-114454

Published: 2008

Includes: Supplemental data

Journal Articles

IgA and IgG Hypogammaglobulinemia Are Associated with Mutations in the APRIL/BLYS Receptor TACI in Waldenstrom’s Macroglobulinemia (WM).

Zachary Hunter, Xavier Leleu, Evdoxia Hatjiharissi, Daniel Santos, Lian Xu, Alan Ho, Vinod Bakthavachalam, Anne-Sophie Moreau, Kelly O’Connor, Jacob Soumerai, Christopher Patterson, Irene Ghobrial, Susanna Hamilton, Sigitas Verselis, Edward Fox, Steven Treon

Blood (2006) 108 (11): 228.

https://doi.org/10.1182/blood.V108.11.228.228

Published: 2006

Journal Articles

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Evdoxia Hatjiharissi, MD, Daniel Ditzel Santos, MD, Lian Xu, Sigitas Verselis, PhD, Michael Modica, PhD, Xavier Leleu, MD, Zachary Hunter, Allen W. Ho, Robert Manning, Christopher Patterson, Kenneth C. Anderson, MD, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 776.

https://doi.org/10.1182/blood.V106.11.776.776

Published: 2005

Journal Articles

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

Evdoxia Hatjiharissi, MD, Mark Hansen, Sigitas Verselis, PhD, Daniel Ditzel Santos, MD, Lian Xu, Robert Manning, Zachary Hunter, Xavier Leleu, MD, Allen W. Ho, Christopher J. Patterson, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 2433.

https://doi.org/10.1182/blood.V106.11.2433.2433

Published: 2005

Journal Articles

Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom’s Macroglobulinemia.

Lian Xu, Xavier Leleu, MD, Zachary R. Hunter, Daniel D. Santos, MD, Allen W. Ho, Evdoxia Hatjiharissi, MD, Kelly O’Connor, Robert J. Manning, Mariana Chemaly, Andrew R. Branagan, Christopher J. Patterson, Sigitas Verselis, Edward Fox, Kenneth C. Anderson, MD, Steven Treon, MD

Blood (2005) 106 (11): 1003.

https://doi.org/10.1182/blood.V106.11.1003.1003

Published: 2005

NARROW

Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets

A Phase I Trial of Escalating Dose of the Rapamycin Analog Everolimus in Combination with the Kinase Inhibitor Midostaurin in Patients (pts) with Relapsed, Refractory or Poor Prognosis Acute Myeloid Leukemia (AML)

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

Molecular Ontogeny of Donor-Derived Lymphomas Occurring After Transplantation,

Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets

Next Generation Sequencing Identifies Novel Oncogene Alterations In CRLF2- rearranged Precursor B-Cell Acute Lymphoblastic Leukemia

Comparison of High Dose Chemotherapy with Autologous Stem Cell Rescue (ASCT) Versus Consolidation Chemotherapy for Patients < 60 with Cytogenetically Normal AML (CN-AML) and Flt3 ITD

Identification of Potential Therapeutic Targets Using Genome-Wide Analysis of Alternative Splicing (AS) In Patients with Acute Myeloid Leukemia (AML)

The Anti-CD20 Monoclonal Antibody GA101 Displays More Robust Anti-Tumor Activity Versus Rituximab In Waldenstrom's Macroglobulinemia (WM)

Clinical Outcomes of Acute Promyelocytic Leukemia (APL) Patients According to FLT3 Mutation Status

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells

Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells

IgA and IgG Hypogammaglobulinemia Are Associated with Mutations in the APRIL/BLYS Receptor TACI in Waldenstrom’s Macroglobulinemia (WM).

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom’s Macroglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only